Somatic mutations and immune checkpoint biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Somatic mutations and immune checkpoint biomarkers

Published:2019-01-12 Issue:3 Volume:24 Page:215-226
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Parris Brielle A.¹²^ORCID,Shaw Eloise¹²,Pang Brendan³,Soong Richie³,Fong Kwun¹²,Soo Ross A.⁴^ORCID

Affiliation:

1. University of Queensland Thoracic Research Centre Brisbane QLD Australia

2. Department of Thoracic MedicineThe Prince Charles Hospital Brisbane QLD Australia

3. Department of PathologyNational University Hospital Singapore

4. Department of Haematology‐OncologyNational University Hospital Singapore

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.13463

Reference85 articles.

1. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)

2. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

3. A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

4. Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers

5. EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p;Journal of Translational Medicine;2024-05-08

2. Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer;JCO Oncology Practice;2024-01

3. Comprehensive Multi-Omics Analysis Reveals NPC2 and ITGAV Genes as Potential Prognostic Biomarkers in Gastrointestinal Cancers;2023-05-26

4. Identification of immune subtypes and response prediction to immune-checkpoint inhibitors for MDM4 gain/amplification luminal A type breast cancer;2023-05-23

5. Immune Deprivation of Growth Factors as Cancer Therapy;Handbook of Cancer and Immunology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3